News
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
13h
ScienceAlert on MSNNew Weight-Loss Drugs Under Scrutiny Amid Pancreas ConcernsPopular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
Weight loss drugs are only effective if you take them consistently. People who pause medication may gain some weight back, especially if they do not make lifestyle changes. GLP-1s can also cause ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results